May

Exogenous surfactant in acute respiratory distress syndrome: more is better Anzueto A. Eur Respir J 2002; 19: 787-789
Indoor swimming pools, water chlorination and respiratory health Nemery B., Hoet P.H.M., Nowak D. Eur Respir J 2002; 19: 790-793
ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Demedts M., Costabel U. Eur Respir J 2002; 19: 794-796
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties Gunther A., Schmidt R., Harodt J., Schmehl T., Walmrath D., Ruppert C., Grimminger F., Seeger W. Eur Respir J 2002; 19: 797-804
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics Walmrath D., Grimminger F., Pappert D., Knothe C., Obertacke U., Benzing A., Gunther A., Schmehl T., Leuchte H., Seeger W. Eur Respir J 2002; 19: 805-810
Lung emptying in patients with acute respiratory distress syndrome: effects of positive end-expiratory pressure Kondili E., Prinianakis G., Athanasakis H., Georgopoulos D. Eur Respir J 2002; 19: 811-819
Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome Kesecioglu J., Schultz M.J., Haitsma J.J., den Heeten G.J., Lachmann B. Eur Respir J 2002; 19: 820-826
Occupational asthma caused by chloramines in indoor swimming-pool air Thickett K.M., McCoach J.S., Gerber J.M., Sadhra S., Burge P.S. Eur Respir J 2002; 19: 827-832
Adaptation to organic dust exposure: a potential role of l-selectin shedding? Israel-Assayag E., Cormier Y. Eur Respir J 2002; 19: 833-837
Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren Horak F., Studnicka M., Gartner C., Spengler J.D., Tauber E., Urbanek R., Veiter A., Frischer T. Eur Respir J 2002; 19: 838-845
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Plaza V., Serrano J., Picado C., Sanchis J. Eur Respir J 2002; 19: 846-852
The prevalence of asthma and asthma-like symptoms among adults in rural Beijing, China Chan-Yeung M., Zhang L-X., Tu D-H., Li B., He G-X., Kauppinen R., Nieminen M., Enarson D.A. Eur Respir J 2002; 19: 853-858
Nasal and oral contribution to inhaled and exhaled nitric oxide: a study in tracheotomized patients Tornberg D.C.F., Marteus H., Schedin U., Alving K., Lundberg J.O.N., Weitzberg E. Eur Respir J 2002; 19: 859-864
Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline Richter K., Janicki S., Jorres R.A., Magnussen H. Eur Respir J 2002; 19: 865-871
Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Acuna A.A., Gabrijelcic J., Uribe E.M., Rabinovich R., Roca J., Barbera J.A., Chung K.F., Rodriguez-Roisin R. Eur Respir J 2002; 19: 872-878
Distribution and degranulation of airway mast cells in normal and asthmatic subjects Carroll N.G., Mutavdzic S., James A.L. Eur Respir J 2002; 19: 879-885
Annual lung function changes in young patients with chronic lung disease Merkus P.J.F.M., Tiddens H.A.W.M., de Jongste J.C. Eur Respir J 2002; 19: 886-891
Socioeconomic deprivation and asthma prevalence and severity in young adolescents Poyser M.A., Nelson H., Ehrlich R.I., Bateman E.D., Parnell S., Puterman A., Weinberg E. Eur Respir J 2002; 19: 892-898
The effects of respiratory infections, atopy, and breastfeeding on childhood asthma Oddy W.H., de Klerk N.H., Sly P.D., Holt P.G. Eur Respir J 2002; 19: 899-905
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine Behr J., Degenkolb B., Krombach F., Vogelmeier C. Eur Respir J 2002; 19: 906-911
Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene Libura J., Bettens F., Radkowski A., Tiercy J.M., Piguet P.F. Eur Respir J 2002; 19: 912-918
Expiratory flow limitation during exercise in COPD: detection by manual compression of the abdominal wall Abdel Kafi S., Serste T., Leduc D., Sergysels R., Ninane V. Eur Respir J 2002; 19: 919-927
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? Willaert W., Daenen M., Bomans P., Verleden G., Decramer M. Eur Respir J 2002; 19: 928-935
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial Aalbers R., Ayres J., Backer V., Decramer M., Lier P.A., Magyar P., Malolepszy J., Ruffin R., Sybrecht G.W. Eur Respir J 2002; 19: 936-943
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia Prats E., Dorca J., Pujol M., Garcia L., Barreiro B., Verdaguer R., Gudiol F., Manresa F. Eur Respir J 2002; 19: 944-951
Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels Yang B., Yao D.F., Ohuchi M., Ide M., Yano M., Okumura Y., Kido H. Eur Respir J 2002; 19: 952-958
Noninvasive ventilation after intubation and mechanical ventilation Ferrer M., Bernadich O., Nava S., Torres A. Eur Respir J 2002; 19: 959-965
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Sohy C., Pilette C., Niederman M.S., Sibille Y. Eur Respir J 2002; 19: 966-975
Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Morales P., Martinez M.A., Vera F., Romero G. Eur Respir J 2002; 19: 976-979
Symptoms of asthma, bronchial responsiveness and atopy in immigrants and emigrants in Europe Kalyoncu A.F. Eur Respir J 2002; 19: 980-983